Fact CheckerSign in

NCT07190274Not yet recruiting

Prospective Observational Cohort Study on Impact of Frailty on Risk Prediction, Treatment Strategies, and Short-Term Outcomes in Patients With Acute Coronary Syndrome

Impact of Frailty on Risk Prediction, Treatment Strategies, and Short-Term Outcomes in Patients With Acute Coronary Syndrome

Source: ClinicalTrials.gov · Last updated 24 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

we aim : * To evaluate how frailty influences acute management decisions (invasive vs conservative strategy) in ACS patients and whether it independently affects short-term outcomes. * To determine whether adding frailty assessment to existing ACS risk prediction models improves the prediction of 30-day mortality and major adverse cardiovascular events (MACE) in elderly ACS patients.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
645 (estimated)
First submitted
16 Sept 2025
Start date
1 Dec 2025
Primary completion date
1 Dec 2027
Lead sponsor
Assiut University
NCT number
NCT07190274

What you commit to

  • Study type: Observational
  • Planned participants: 645
  • From 1 Dec 2025 to the primary completion date, 1 Dec 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Terminal illness (life expectancy \<1 month)
  • Severe dementia precluding assessment

Other

  • Declined consent

Who the study is looking for

  • Elderly: Age ≥65 years .
  • STEMI/NSTEMI (ESC/ACC criteria)
  • Presentation \<24h of symptom onset

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.